Lyell Immunopharma Inc
NASDAQ:LYEL

Watchlist Manager
Lyell Immunopharma Inc Logo
Lyell Immunopharma Inc
NASDAQ:LYEL
Watchlist
Price: 1.075 USD -2.27% Market Closed
Market Cap: 275.2m USD
Have any thoughts about
Lyell Immunopharma Inc?
Write Note

Lyell Immunopharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lyell Immunopharma Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Lyell Immunopharma Inc
NASDAQ:LYEL
Revenue
$130k
CAGR 3-Years
-74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

See Also

What is Lyell Immunopharma Inc's Revenue?
Revenue
130k USD

Based on the financial report for Dec 31, 2023, Lyell Immunopharma Inc's Revenue amounts to 130k USD.

What is Lyell Immunopharma Inc's Revenue growth rate?
Revenue CAGR 3Y
-74%

Over the last year, the Revenue growth was -100%. The average annual Revenue growth rates for Lyell Immunopharma Inc have been -74% over the past three years .

Back to Top